175 related articles for article (PubMed ID: 7346154)
21. Ternary complex formation with 5-fluoro-2'-deoxyuridylate and the kinetic properties of thymidylate synthase from Lactobacillus leichmannii.
Rao KN
Indian J Biochem Biophys; 1993 Apr; 30(2):103-10. PubMed ID: 8354517
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of mammalian tumour thymidylate synthetase by 2'-deoxyuridine 5'-phosphate analogues.
Rode W; Kulikowski T; Kedzierska B; Shugar D
Drugs Exp Clin Res; 1986; 12(6-7):545-9. PubMed ID: 3743372
[TBL] [Abstract][Full Text] [Related]
24. Development of an LC-MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil.
Derissen EJ; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2015 Jun; 110():58-66. PubMed ID: 25804433
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanism of thymidylate synthase-catalyzed reaction and interaction of the enzyme with 2- and/or 4-substituted analogues of dUMP and 5-fluoro-dUMP.
Rode W; Leś A
Acta Biochim Pol; 1996; 43(1):133-42. PubMed ID: 8790719
[TBL] [Abstract][Full Text] [Related]
26. A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes.
Liao ZY; Sordet O; Zhang HL; Kohlhagen G; Antony S; Gmeiner WH; Pommier Y
Cancer Res; 2005 Jun; 65(11):4844-51. PubMed ID: 15930305
[TBL] [Abstract][Full Text] [Related]
27. Relative free energies of binding to thymidylate synthase of 2- and/or 4-thio and/or 5-fluoro analogues of dUMP.
Jarmuła A; Cieplak P; Leś A; Rode W
J Comput Aided Mol Des; 2003 Oct; 17(10):699-710. PubMed ID: 15068368
[TBL] [Abstract][Full Text] [Related]
28. Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.
Reilly RT; Barbour KW; Dunlap RB; Berger FG
Mol Pharmacol; 1995 Jul; 48(1):72-9. PubMed ID: 7623777
[TBL] [Abstract][Full Text] [Related]
29. Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients.
Hoshino S; Yamashita Y; Maekawa T; Shirakusa T
Cancer Chemother Pharmacol; 2005 Dec; 56(6):648-52. PubMed ID: 15959779
[TBL] [Abstract][Full Text] [Related]
30. [Mechanism of action of anti-cancer drugs from the viewpoint of RNA metabolism].
Kanamaru R; Wakui A
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1011-8. PubMed ID: 3291764
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations.
Tanaka M; Kimura K; Yoshida S
Cancer Res; 1983 Nov; 43(11):5145-50. PubMed ID: 6225512
[TBL] [Abstract][Full Text] [Related]
32. The effect of 5-substitution in the pyrimidine ring of dUMP on the interaction with thymidylate synthase: molecular modeling and QSAR.
Jarmuła A; Cieplak P; Krygowski TM; Rode W
Bioorg Med Chem; 2007 Mar; 15(6):2346-58. PubMed ID: 17275316
[TBL] [Abstract][Full Text] [Related]
33. In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cells.
Qin B; Tanaka R; Ariyama H; Shibata Y; Arita S; Kusaba H; Baba E; Harada M; Nakano S
Anticancer Drugs; 2006 Apr; 17(4):439-43. PubMed ID: 16550002
[TBL] [Abstract][Full Text] [Related]
34. Angiostrongylus cantonensis: characterization of thymidylate synthetase.
So NN; Wong PC; Ko RC
Exp Parasitol; 1994 Dec; 79(4):526-35. PubMed ID: 8001663
[TBL] [Abstract][Full Text] [Related]
35. Development, characterization and application of an antibody against 5-fluoro-2'deoxyuridine-5'monophosphate, the active metabolite of 5-fluorouracil.
Peters GJ; Laurensse E; Steinbusch HW; De Vente J; Smid K; Van der Wilt CL; Pinedo HM
Anticancer Res; 1993; 13(4):835-9. PubMed ID: 8352551
[TBL] [Abstract][Full Text] [Related]
36. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
Klubes P; Connelly K; Cerna I; Mandel HG
Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
[No Abstract] [Full Text] [Related]
37. Creation and characterization of 5-fluorodeoxyuridine-resistant Arg50 loop mutants of human thymidylate synthase.
Landis DM; Heindel CC; Loeb LA
Cancer Res; 2001 Jan; 61(2):666-72. PubMed ID: 11212266
[TBL] [Abstract][Full Text] [Related]
38. Thymidylate synthetase - substrate complex formation.
Danenberg PV; Lockshin A
Mol Cell Biochem; 1982 Mar; 43(1):49-57. PubMed ID: 7078549
[TBL] [Abstract][Full Text] [Related]
39. Determinants of 5-fluorouracil sensitivity in human tumors.
Moran RG; Heidelberger C
Bull Cancer; 1979; 66(1):79-83. PubMed ID: 420950
[TBL] [Abstract][Full Text] [Related]
40. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
